Find clinical trials for Prostate Cancer in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Montréal, QC, CAN:
177Lu PSMA 617 is a new type of therapy which is designed to deliver high doses of radiation directly to prostate cancer sites in t ...
Phase 2
Montreal, Quebec, Canada and 9 other locations
ACCEL is a multicenter, open label phase I/II study of \[Ac-225\]-PSMA-62 in participants with prostate-specific membrane antigen (PSMA)-pos ...
Phase 1
Montréal, Quebec, Canada
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Montréal, Quebec, Canada and 92 other locations
The purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-560219...
Phase 1
Montreal, Quebec, Canada and 6 other locations
Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...
Phase 1
Montreal, Quebec, Canada and 17 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Montreal, Quebec, Canada and 131 other locations
The purpose of this study is to find out what effects a new drug, palbociclib, has on prostate cancer and will look at the side eff...
Phase 2
Montreal, Quebec, Canada and 6 other locations
approach.Participants with high-risk prostate cancer planned for curative-intent standard-of-care radiotherapy or surgery, or with...
Phase 3
Montreal, Quebec, Canada and 18 other locations
Prostate cancer is the second most common cancer among Canadian men of which approximately 20-30% present with high-risk t...
Phase 2
Montréal, Quebec, Canada and 1 other location
It is a phase I study of radical hypofractionation delivering one single fraction of SBRT in patients with low- and favorable intermediate-risk prostate...
Montréal, Quebec, Canada
Clinical trials
Research sites
Resources
Legal